OrthoPediatrics (KIDS) last issued guidance on February 26, 2026 for fiscal year 2026. The company guided revenue in the range of $262.00M - $266.00M for the period.

Compared to prior guidance, OrthoPediatrics raised its revenue forecast from a prior range of $236.10M - $236.10M.

OrthoPediatrics has issued 30 guidance updates between May 4, 2022 and February 26, 2026. During this period, the company raised its outlook 8 times and lowered it 7 times, providing investors with insight into management's evolving expectations.